Drug Database
Back to search

United States· US:16110-247_4f9be4df-4e12-4f08-8e6f-cb07926ea5e6

Seysara

A sarecycline product containing sarecycline hydrochloride, registered in United States by Almirall, LLC.

ATC J01AA14US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSeysaraATCJ01AA14REGISTER NO.US:16110-247_4f9be4df…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sarecycline hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SARECYCLINE HYDROCHLORIDE
Manufacturer
Almirall, LLC
Country
United States (US)
ATC code
J01AA14
ATC class
Sarecycline
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    1611024730
    30 TABLET, COATED in 1 BOTTLE (16110-247-30)
  • ndc11
    16110-247-30

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

158 interactions on record for sarecycline.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sarecycline against other medicinesHow interaction checks work

Sarecycline · interactions on record

158 records

  • 7 severe
  • 146 moderate
  • 5 minor

Most severe, free to view

  • EdoxabanB01AF03severe
  • AcitretinD05BB02severe
  • IsotretinoinD10AD04severe
  • IsotretinoinD10BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J01AA14

Sarecycline, as other registers publish it.

All sarecycline products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7debb4c-3f11-4190-91f3-a2bfef6b5552
GET /v1/drugs/f7debb4c-3f11-4190-91f3-a2bfef6b5552?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "150",
  "substance": "SARECYCLINE HYDROCHLORIDE",
  "productndc": "16110-247",
  "dosage_form": "TABLET, COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA209521",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about sarecycline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console